Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Gains from Sales and Divestitures: 2015-2017

Historic Gains from Sales and Divestitures for Ocugen (OCGN) over the last 3 years, with Dec 2017 value amounting to $1,889.

  • Ocugen's Gains from Sales and Divestitures fell 42.77% to $1,889 in Q4 2017 from the same period last year, while for Dec 2017 it was $1,889, marking a year-over-year decrease of 42.77%. This contributed to the annual value of $1,889 for FY2017, which is 42.77% down from last year.
  • As of FY2017, Ocugen's Gains from Sales and Divestitures stood at $1,889, which was down 42.77% from $3,301 recorded in FY2016.
  • Ocugen's Gains from Sales and Divestitures' 5-year high stood at $3,303 during FY2015, with a 5-year trough of $1,889 in FY2017.
  • For the 3-year period, Ocugen's Gains from Sales and Divestitures averaged around $2,831, with its median value being $3,301 (2016).
  • Data for Ocugen's Gains from Sales and Divestitures shows a maximum YoY crashed of 42.77% (in 2017) over the last 5 years.
  • Ocugen's Gains from Sales and Divestitures (Yearly) stood at $3,303 in 2015, then dropped by 0.06% to $3,301 in 2016, then slumped by 42.77% to $1,889 in 2017.